In Western countries one in two men and one in three women will develop a malignant tumor during their life. In Germany over 486.000 new cases were diagnosed and over 215.000 patients succumbed to their disease in 2012. Because of the increasing number of senior citizens these numbers are likely to increase further in the coming years. The development of new effective strategies to treat and prevent cancer remains a great challenge.
The Georg-Speyer-Haus, Institute for Tumorbiology and Experimental Therapy, aims to decipher the molecular and cellular basis of tumorigenesis. A particular focus is placed on the analysis and the interaction of various cell types within the tumor, the tumor microenvironment. New therapeutic concepts are being tested in valid pre-clinical tumor models. In close collaboration with the University Cancer Center (UCT) and the LOEWE Center Frankfurt Cancer Institute (FCI) as well as as a member of the German Cancer Consortium (DKTK) these concepts are translated into early clinical trials. At our institute we pursue this translational research – from basic research on tumor biology to preclinical studies – by 3 research fields:
Cellular Communication in the Stem Cell Niche
Cell-Cell Interaction in the Tumor Stroma
Learn more in the lab of Prof. Dr. Wels
Read below our annual reports of the latest years 2015-2020 and get to know more about the Georg-Speyer-Haus and the state of research at our Institute for Tumor Biology and Experimental Therapy.